Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 7, 2013; 19(41): 7069-7077
Published online Nov 7, 2013. doi: 10.3748/wjg.v19.i41.7069
Published online Nov 7, 2013. doi: 10.3748/wjg.v19.i41.7069
Classification | Drugs |
Anti-infective agents | Amoxicillin/clavulanateerythromycin, roxithromycin, telithromycin, doxycycline, minocyclinenitrofurantoin, ciprofloxacin, levofloxacin, moxifloxacintrimethoprim-sulfamethoxazole, sulfasalazine, isoniazid, rifampin, pyrazinamide, ethambutol, dapsone,fluconazole, itraconazole, terbinafine, ketoconazole, chloroquineDidanosine, fialuridine, efavirenz, abacavir, nevirapine-lamivudine |
Cardiovascular agents | Amiodarone, labetalol, diltiazem, methyldopa, valsartan, lisinopril, angiotensin converting enzyme inhibitorAsparaginase, flutamide |
Hypolipidemic agents | Atorvastatin, cerivastatin, simvastatin, pravastatin, fluvastatin, ezetimibe |
Hypoglycemic Agents | Metformin, troglitazone |
Anti-allergic agents | Zafirlukast, loratadine, diphenhydramine |
Herbal products/dietary supplements | Kava, Herbalife, Comfrey, Senecio, Greater Celandine, Polygonum multiflorum, ginseng, Teucrium polium, usnic acid, ma huang, Chaso, Onshido, Hydroxycut, LipoKinetix |
Neurological and psychiatric drugs | Halothane, isoflurane, butorphanolopiates, amphetamines, marijuana, cocainePhenytoin, valproic acid, carbamazepine, felbamate, lamotrigine, vigabatrinamitriptyline, imipramine, sertraline, paroxetine, venlafaxine, pemoline, bupropionChlorpromazine, quetiapine, clonazepamtolcapone |
Nonsteroidal anti-inflammatory drugs | Diclofenac, bromfenac, etodolac, naproxen, ibuprofen, indometacin |
Miscellaneous | Propylthiouracil, retinol, infliximab, allopurinol, cyclosporine, disulfiram, iron sulfate, anabolic steroids, carbon tetrachloride, phenprocoumon, nicotinic acid |
Antineoplastic agents | Methotrexate, cytoxan, etoposide, dactinomycin, azathioprine, tamoxifen |
Acetaminophen-induced ALF | Non-acetaminophen-induced ALF |
Strongly recommended list for OLT if: Arterial lactate > 3.5 mmol/L after early fluid resuscitation | List for transplantation if: INR > 6.5 and encephalopathy present irrespective of grade |
List for transplantation if: Arterial pH < 7.3 or arterial lactate > 3.0 mmol/L after adequate fluid resuscitation | Or if any 3 of the following features (encephalopathy irrespective of grade) are present: |
Age < 10 yr or > 40 yr1 | |
Interval from jaundice to encephalopathy > 7 d1 | |
List for transplantation if all 3 of the following occur within a 24-h period: Grade 3 or 4 hepatic encephalopathy INR > 6.5 Creatinine > 300 μmol/L | INR ≥ 3.5 |
Serum bilirubin ≥ 300 μmol/L | |
Unfavorable etiology, such as seronegative hepatitis, idiosyncratic drug reaction or Wilson disease |
- Citation: Wang DW, Yin YM, Yao YM. Advances in the management of acute liver failure. World J Gastroenterol 2013; 19(41): 7069-7077
- URL: https://www.wjgnet.com/1007-9327/full/v19/i41/7069.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i41.7069